Clinical Trials

LymphoidOther hematologic neoplasm

152 enrolled

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Recurrence, Hematologic Neoplasms

NCT04421963 2026-04-16

ROSY-O

Phase 3 Active not recruiting

185 enrolled

BreastGynecologic

Breast Neoplasms, Neoplasms, Ovarian Neoplasms

NCT06959706 2026-04-16

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors

50 enrolled

Carcinoma, Neoplasms

NCT07075185 2026-04-16

inMMyCAR

40 enrolled

LymphoidPlasma cell

Blood Protein Disorders, Disease, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Hemostatic Disorders

NCT07100730 2026-04-16

IPAX BrIGHT

50 enrolled

CNS

Brain Neoplasms, Glioblastoma, Neoplasm Recurrence, Local, Neoplasms, Central Nervous System Neoplasms

NCT07504458 2026-04-16

QUATRO-APL

Other hematologic neoplasm

150 enrolled

Hematologic Diseases, Leukemia, Neoplasms, Leukemia, Promyelocytic, Acute, Hematologic Neoplasms

NCT01481532 2026-04-15

Open Label Clinical Trial of Intravenous Crotoxin Part 3

Phase 1 Not yet recruiting

24 enrolled

Phase 3 Active not recruiting

Neoplasms

NCT04464226 2026-04-15

Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

402 enrolled

Neoplasms

NCT04486378 2026-04-15

A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

Phase NA Active not recruiting

327 enrolled

Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT04905069 2026-04-15

SABRE

500 enrolled

Genitourinary

Neoplasms, Prostatic Neoplasms

NCT05376891 2026-04-15

Met Non Small Cell Cancer Registry (MOMENT)

Recruiting

700 enrolled

Phase 2 Active not recruiting

Neoplasms

NCT06502977 2026-04-15

DeLLphi-307

32 enrolled 9 charts

EndocrineNET

Neoplasms, Neuroendocrine Tumors

NCT06634589 2026-04-15

A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

80 enrolled

Lymphoid

Neoplasms, Recurrence, Lymphoma, B-Cell

NCT07005102 2026-04-15

A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Phase 2/3 Recruiting

854 enrolled

Neoplasms

NCT07094204 2026-04-15

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

364 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT07216443 2026-04-15

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

MyeloidOther hematologic neoplasmOther neoplasm

80 enrolled

Acute Disease, Bone Marrow Diseases, Disease, Graft vs Host Disease, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Myelodysplastic Syndromes, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Precancerous Conditions, Preleukemia, Syndrome, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Disease Attributes

NCT07529808 2026-04-15

ChefHat-001

Phase 1/2 Not yet recruiting

164 enrolled

Gastrointestinal

Adenocarcinoma, Colonic Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT07530666 2026-04-15

Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia

Phase 1/2 Not yet recruiting

58 enrolled

Cachexia, Neoplasms

NCT07532018 2026-04-15

DXP-106

54 enrolled

Neoplasms

NCT04928846 2026-04-14

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Phase 1 Active not recruiting

698 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT04958239 2026-04-14

A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer

151 enrolled

Neoplasms

NCT05382559 2026-04-14

A Study of ASP3082 in Adults With Advanced Solid Tumors

681 enrolled

Phase NA Active not recruiting

Neoplasm Metastasis, Neoplasms

NCT05611632 2026-04-14

NHS-Galleri

142,318 enrolled

Neoplasms

NCT06150157 2026-04-14

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

220 enrolled

Neoplasms

NCT06906341 2026-04-14

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

270 enrolled

Gynecologic

Fallopian Tube Diseases, Fallopian Tube Neoplasms, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Neoplasms, Endometrial Neoplasms

NCT07409246 2026-04-14

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

Phase 2 Active not recruiting

127 enrolled

Plasma cell

Multiple Myeloma, Neoplasms

NCT02864992 2026-04-13

VISION

337 enrolled 13 charts 4 FDA

Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT02908906 2026-04-13

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers

Phase 1/2 Active not recruiting

413 enrolled

Phase 3 Active not recruiting

Neoplasms

NCT03148418 2026-04-13

A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)

382 enrolled

Neoplasms

NCT03555422 2026-04-13

ENGOT-EN5

Phase 3 Completed

263 enrolled

Gynecologic

Genital Diseases, Neoplasms, Neoplasms by Site, Uterine Diseases, Uterine Neoplasms, Endometrial Neoplasms

NCT03686124 2026-04-13

ACTengine

Phase 1 Active not recruiting

375 enrolled

DermatologicGynecologic

Uveal Melanoma, Melanoma, Neoplasms, Ovarian Neoplasms, Recurrence

NCT04606381 2026-04-13

PALOMA

158 enrolled

Neoplasms

NCT05120596 2026-04-13

First in Human Study of T3P-Y058-739 (T3P)

100 enrolled

Phase NA Active not recruiting

Neoplasms

NCT05155605 2026-04-13

PATHFINDER 2: A Multi-Cancer Early Detection Study

35,885 enrolled

Neoplasms

NCT05257590 2026-04-13

CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma

95 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms

NCT05283720 2026-04-13

A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma

LymphoidOther hematologic neoplasm

496 enrolled

Leukemia, Hairy Cell, Lymphoma, Non-Hodgkin, Neoplasms, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT05377554 2026-04-13

Bevonescein for Intra-Operative Nerve Visualization in Head and Neck Surgery

Phase 3 Completed

154 enrolled

Neoplasms

NCT05862285 2026-04-13

UmbrellaMAX

100 enrolled

Neoplasms

NCT06012695 2026-04-13

NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma